Possible Therapeutic Effect of Chitosan Nanoparticles versus Pioglitazone Loaded Chitosan Nanoparticles on Colitis Associated with Chronic Kidney Disease in Adult Male Albino Rat Model. Histological and Biochemical Study | ||||
| Egyptian Journal of Histology | ||||
| Article 2, Volume 48, Issue 2, June 2025, Page 412-431 PDF (12.03 MB) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/ejh.2024.291579.2070 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Rokia Mohamad Hassan 1; Safinaz Salah Eldin Sayed 2; Alaa Serag El-dean Habib 2; Marwa Mohamed Yousry  2
| ||||
| 1Histology and cell biology Faculty of Medicine Cairo University | ||||
| 2Histology Department, Faculty of Medicine, Cairo University, Cairo, Egypt | ||||
| Abstract | ||||
| Background: One of the pathogenic factors and a complication of chronic kidney disease (CKD) is colitis and intestinal dysbiosis. Pioglitazone hydrochloride (PIO), an antidiabetic medication which stimulates peroxisome proliferator-activated receptor-γ (PPAR-γ) & possess antioxidant and anti-inflammatory effects. Low aqueous solubility of PIO results in limited absorption and pharmacodynamics. Therefore, a drug delivery system nanoparticle is a priority. Aim of Work: Assessing the potential therapeutic impact of chitosan nanoparticles versus PIO-loaded chitosan nanoparticles on colitis associated with CKD. Materials & Methods: Twenty-nine adult male rats were categorized into 5 groups: group I, group II administered adenine daily for 3 weeks, group III treated as group II then no further intervention for 2 weeks, groups IV & V received adenine as group II then treated with chitosan nanoparticles and PIO-loaded chitosan nanoparticles respectively for 2 weeks. Biochemical analysis for stool lactobacilli, serum creatinine, colonic malondialdehyde (MDA), tumor necrosis factor-α (TNF-α) and PPAR-γ along with histological and immunohistochemical study (for claudin-1 and caspase-3) were performed. In addition to statistical analysis. Results: Group II illustrated elevated serum creatinine, colonic MDA and TNF-α as well as decreased stool lactobacilli and PPAR-γ expression. Disruption of renal architecture along with lost colonic surface epithelium, distorted intestinal crypt and inflammatory infiltration were recorded. In addition to reduced claudin-1 and increased caspase-3 immunoreactivity. As regards group III, no significant improvement was recorded in all the previously mentioned findings. While groups IV and V revealed obvious amelioration with better effects in group V. Conclusion: Both chitosan nanoparticles and pioglitazone loaded chitosan nanoparticles improved alteration of kidney function and structure and ameliorated colitis associated with CKD. While pioglitazone loaded chitosan nanoparticles illustrated superior impacts. | ||||
| Keywords | ||||
| Chronic kidney disease induced colitis; claudin-1; intestinal microbiota; pioglitazone chitosan nanoparticles; PPAR-γ | ||||
|
Statistics Article View: 284 PDF Download: 114 |
||||
